OSHA Issues New Workplace Opioid Overdose Guidance
The new guidance helps employers train staff to recognize symptoms and administer life-saving reversal medications.
Updated on Oct. 29, 2026 in Substance Abuse
Live Poll
Should employers be required to provide opioid overdose reversal medication at worksites?
OSHA has released new guidance to help employers recognize opioid overdose symptoms and provide life-saving reversal medications in the workplace. This advisory aims to better prepare businesses for medical emergencies as fentanyl remains prevalent in the national drug landscape.
Why it matters
The guidance addresses a growing occupational health crisis, following 410 fatal drug or alcohol-related workplace injuries recorded by the Bureau of Labor Statistics in 2024. Providing clear protocols helps employers move beyond awareness to actionable safety measures for their staff.
Official government data tracked 410 fatal occupational drug or alcohol overdoses in 2024, while a separate National Safety Council survey shows only 28% of employers currently stock naloxone. The effectiveness of this new federal guidance for workplace-wide implementation remains under study.
The players
Occupational Safety and Health Administration
A federal agency that sets and enforces standards for workplace safety and health across the United States.
Global Health Advocacy Incubator
An organization that supports public health policy change and capacity building, hosting upcoming naloxone training on Capitol Hill.
Bureau of Labor Statistics
The federal agency that produces labor market, working conditions, and price change information for the U.S. government.
The details
The OSHA guidance directs employers to maintain overdose kits in visible, accessible locations and conduct training for staff on identifying overdose symptoms. Workers are instructed on the proper administration of FDA-approved reversal medications, naloxone and nalmefene. The agency emphasizes that while these medications are critical, they do not replace the need to call emergency services during a medical crisis.
Timeline
In 2024, the Bureau of Labor Statistics recorded 410 fatal occupational injuries involving drug or alcohol overdose.
On October 29, 2026, OSHA issued new workplace opioid emergency guidance.
On November 19, 2026, the Global Health Advocacy Incubator will host congressional naloxone training.
Health Landscape
This guidance serves as an official clinical component of the broader Great American Recovery Initiative. It updates the standard of occupational safety by integrating overdose recognition into general workplace preparedness alongside traditional first-aid protocols.
If you are an employer or safety manager, review the new OSHA fact sheet to determine if your facility's emergency protocols need updating. You may want to discuss with your physician or local health department how to properly store and administer reversal medications like naloxone.
The takeaway
Workplace safety now increasingly requires preparedness for potential opioid emergencies due to the rise of fentanyl in the illicit drug supply. Employees should familiarize themselves with their company's emergency response plan and the location of available overdose reversal kits.
What happens next
The Global Health Advocacy Incubator is scheduled to host a naloxone training session on Capitol Hill on November 19, 2026.
Further reading
For more information on recognizing and responding to crises, visit the Substance Abuse section.
Source note: This article includes information reported by Roofing Contractor.
Live Poll
Should employers be required to provide opioid overdose reversal medication at worksites?
